Gilead Says Counterfeit Ring Swiped Its HIV Drug Branding

By Lauren Berg (January 18, 2022, 9:37 PM EST) -- Gilead Sciences said a massive ring of small-time drug distributors and pharmacists was filling the biotech company's branded HIV medication bottles with potentially dangerous drugs and selling the counterfeit pills to patients, according to a civil case unsealed Tuesday in New York federal court.

Gilead's investigation found that more than 85,000 counterfeit bottles labeled as Gilead-branded medication have been sold to pharmacies over the past two years, altogether worth about $250 million, according to Lori Mayall, head of anti-counterfeiting and brand protection at Gilead.

"The health and safety of individuals who rely on our life-saving medications is our first priority," Mayall...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!